ematologists tentative rogram · title: paroxysmal nocturnal hemoglobinuria: a multicenter study...

Hematologists 2018conferenceseries.com

http://hematology.conferenceseries.com/europe/

***For available speaker slots***[email protected]

Tentative Program12th World Hematologists Congress

March 15-16, 2018 London, UK

InteractiveSessions

KeynoteLectures

Exhibitors B2BMeetings

PlenaryLectures Workshops



Program at a Glance

Session 1 Session 2

Morning

Session

s

29 S

peak

ers f

or Day 1

General SessionInaugural Address

Keynote Session

Keynote/Plenary Talk 1 (Slot Available)

2nd International Conference & Expo on

Optometry and Vision ScienceSeptember 11-12, 2017 Paris, France

Program at a GlanceDay 1


Lunch Break 6 Speakers (20 min) slot avilable

Panel Discussions/Group Photo

5 Speaker (20 min) slot avilable


Coffee/Tea Break (Networking)



Even

ing Sessions Lunch Break5 Speaker (20 min) slot avilable

Poster Sessions

Even

ing Sessions


NOTE: Program Shedule is subject to change with final allotment of the speaker slotsFor more Details PS: http://optometry.conferenceseries.com

[email protected]| [email protected]

Day 2

Morning

Session

s

Awards & Closing Ceremony

Coffee/Tea Break (Networking)5 Speaker (20 min) slot avilable

30 S

peak

ers o

n Day 2



http://hematology.conferenceseries.com/europe/e-mail: [email protected]; [email protected]



Conference Highlights• Hematology

• Hematologic Disorders

• Blood Disorders

• Hematology Oncology

• Hematology Nursing

• Pediatric Hematology

• Veterinary Hematology

• Blood Disorders: Diagnosis & Treatment

• Hematopathology

• Immunohematology

• Stem Cell Research

• Clinical and Experimental Hematology

• Pharmaceutical Hematology

• Biomarkers in Hematology

• Clinical trials

• Case reports and Epidemiology

For detailed sessions, please visit: http://hematology.conferenceseries.com/europe/

Submit your abstract online at: http://hematology.conferenceseries.com/europe/abstract-submission.php

Register online: http://hematology.conferenceseries.com/europe/registration.php



Glimpses of Hematology Conferences



Plan your Trip to London

Big Ben: London’s iconic national timepiece Buckingham Palace: Home of the British Queen and state rooms.

London at Night Time

Palace of Westminster: Iconic home of UK parliament. London Eye: Iconic riverside observation wheel.

conferenceseries.com937th Conference

Conference Series - America2360 Corporate Circle., Suite 400, Henderson, NV 89074-7722, USA

P: 702-508-5200, F: +1-650-618-1417

Conference Series - UK57 Ullswater Avenue, West End, Southampton, Hampshire, United Kingdom, SO18 3QS

Toll Free: +1-800-216-6499

May 08-09, 2017 Barcelona, Spain

Proceedings of

7th World Hematologists Congress

Scientific Program

RegistrationsDay 1 May 08, 2017

Keynote ForumIntroductionTitle: Coagulopathy in traumatic brain injury: Current concepts and controversiesJohn Batchelor, Central Manchester Foundation Trust, UKTitle: Study and summary of NK/T cell lymphoma from Lymphoma Diagnosis and Treatment Center in Henan province of ChinaMingzhi Zhang, First Affiliated Hospital of Zhengzhou University, China

Networking and Refreshment BreakTitle: The Saudi experience on the effects of endocrine complications and its morbidity in thalassemia and the role of collaboration with international network of clinicians for endocrinopathies in thalassemia and adolescent medicine (ICET-A)Soad K Al Jaouni, King Abdulaziz University, KSASessions: Hematology|Blood Disorders: Diagnosis and Treatment|Hematology OncologySession Chair: M Dahmani Fathallah, Arabian Gulf University, BahrainSession Co-Chair: Natalia Neparidze, Yale School of Medicine, USA

Session IntroductionTitle: Serine protease homolog from snake venom, a promising new anticoagulant lead moleculeIgor Križaj, Jožef Stefan Institute, SloveniaTitle: Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: Influence on treatment decisionsNatalia Neparidze, Yale School of Medicine, USA

Group Photo Lunch Break

Title: Characterization and management of synchronous dual hematological malignanciesRouslan Kotchetkov, Royal Victoria Regional Heath Centre, CanadaTitle: Hydroxyurea, an effective therapy to avoid splenectomy in sickle cell disease and thalassemia: Single institute experience in Saudi ArabiaSoad K Al Jaouni, King Abdulaziz University, KSATitle: PD1-PDL1 axis in lymphoproliferative diseases: The pathologist’s point of viewAntonella Bianchi, Università Campus Bio-Medico, ItalyTitle: A novel bispecific recombinant biological agent modulating inflammation’s early cellular eventsM Dahmani Fathallah, Arabian Gulf University, BahrainTitle: Ischaemia in pancreatic cancerAisha Patel, Gloucestershire NHS Trust, UK YRF

Networking and Refreshment BreakTitle: A flow cytometric assay for the confirmation of heparin-induced thrombocytopenia (HIT)Elvira Maličev, Blood Transfusion Centre of Slovenia, SloveniaTitle: Paroxysmal nocturnal hemoglobinuria: A multicenter study from Saudi ArabiaSalem Khalil, King Faisal Specialist Hospital and Research Centre, Saudi ArabiaTitle: Thalassemia minor diagnostics by a computational methodYulia Einav, Holon Institute of Technology, Israel

Opening Ceremonyconferenceseries.com

Orly

Title: Incidence, natural history and outcome of targeted therapy-induced cardiotoxicity in hematologic malignancy (HM) patientsChintan Shah, University of Florida, USA VP

Panel DiscussionDay 2 May 09, 2017

OrlyKeynote Forum

Title: Pathogenesis of thrombosis in myeloproliferative neoplasmsJean-Francois Schved, Montpellier University Hospital, FranceTitle: Genomics, gene editing & biological drugs: The bolsters of the new medical paradigmM Dahmani Fathallah, Arabian Gulf University, BahrainSessions: Blood Disorders|Hematology and Its Various Aspects| Case ReportsSession Chair: John Batchelor, Central Manchester Foundation Trust, UK

Session Co Chair: Rouslan Kotchetkov, Royal Victoria Regional Heath Centre, Canada

Session IntroductionTitle: Dynamic apperception of the sick germinal centre insights gleaned by follow-up of early-pattern angioimmunoblastic T-cell lymphoma and its immune-architectural comparison with reactive lymphoid hyperplasiaLeonard Tan, Singapore General Hospital, SingaporeTitle: Nigella Sativa and honey improves quality of life in Kostmann syndrome: Case reportSoad K Al Jaouni, King Abdulaziz University, KSA

Networking and Refreshment BreakTitle: Progress in diagnosis and treatment of advanced NK/T cell lymphomaMingzhi Zhang, First Affiliated Hospital of Zhengzhou University, ChinaTitle: Management of cardiovascular disease in hemophiliaJean-Francois Schved, Montpellier University Hospital, FranceTitle: Implementing NAT & universal parasitic screening for blood donors: Maximizing donor surveillanceAyesha Junaid, Shifa International Hospital, PakistanTitle: ABO and rhesus D blood group and haemolytic disease among the new-born at Sokoto Specialist Hospital, NigeriaOsaro Erhabor, Usmanu Danfodiyo University, Nigeria

Lunch BreakTitle: The diagnostic value of serum squamous cell carcinoma antigen (SCCA) for prediction of HCC patientsSally Saad Mandour Esawy, National Liver Institute, Menoufia University, EgyptTitle: Some iron parameters among transfusion-dependent subjects in Maiduguri, Nigeria: The case for provision of chelating agents in developing countriesOsaro Erhabor, Usmanu Danfodiyo University, NigeriaTitle: Assessment of coagulation profile, fibrinogen, protein C, protein S, antithrombin, and vitamin K levels among Sudanese neonates with proven sepsis in Omdurman Maternity Hospital, SudanAlbara Abdulfatah Mohammed, University of Khartoum, SudanTitle: Mutational analysis in hematological diseases Salem Khalil, King Faisal Specialist Hospital and Research Centre, Saudi Arabia

Networking and Refreshment BreakTitle: L-arginine/5-fu combination preferentially rescues normal cells from apoptosis and not cancer cellsKamran Mansouri, Kermanshah University of Medical Sciences, Iran

Poster @ Meeting Halls

Panel DiscussionAward & Closing Ceremony

Bookmark your dates

E: [email protected]; [email protected] Website: hematology.conferenceseries.com/europe

March 15-16, 2018 London, UK12th World Hematologists Congress

622nd Conferenceconferenceseries.com

Scientific Program

5th World Hematologists CongressAugust 18-19, 2016 London, UK

Hosting Organizations: Conference Series LLC2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA

Ph: +1-702-508-5200 Ext: 8044, Fax: +1-650-618-1417, Toll free: +1-800-216-6499

Conference Series LtdHeathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, UK, Tel: +1-800-216-6499

Email: [email protected]; [email protected]

RegistrationsGuggenheum

Day 1 August 18, 2016

Networking & Refreshment BreakMajor Sessions: Hematology | Hematologic OncologySession Chair: John Batchelor, Central Manchester Foundation Trust, UKSession Co-chair: Shaoying Li, University of Texas MD Anderson Cancer Center, USA

Session IntroductionTitle: MYC/BCL2 double hit high grade B-cell lymphomaShaoying Li, University of Texas MD Anderson Cancer Center, USATitle: The management of traumatic intracranial hemorrhage in patients taking pre-injury antiplatelet agents: An updateJohn Batchelor, Central Manchester Foundation Trust, UKTitle: Clinical applications of immunoglobulin expression in acute myeloid leukemiaC Cameron Yin, University of Texas MD Anderson Cancer Center, USATitle: Treating polycythemia vera with Ruxolitinib: An update from the RESPONSE 1 & 2 trialsSimon Durrant, University of Queensland, AustraliaTitle: L-arginine and nitric oxide levels among hypertensive patient in Sokoto, North Western NigeriaErhabor Osaro, Usmanu Danfodiyo University, Nigeria

Group PhotoLunch Break

Major Sessions: Blood Disorders|Diagnosis of Blood DisordersSession Chair: C Cameron Yin, University of Texas MD Anderson Cancer Center, USASession Co-chair: Rashmi Kanagal-Shamanna, University of Texas MD Anderson Cancer Center, USA

Session IntroductionTitle: Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: From Dameshek 1950 to Vainchenker 2005 and beyondJ J Michiels, Goodheart Institute, NetherlandsTitle: Clinical significance of CD5 expression in B-cell lymphomasC Cameron Yin, University of Texas MD Anderson Cancer Center, USATitle: Repurposed therapies in AML and MDSKen Mills, Queen’s University Belfast, UKTitle: Myeloid neoplasms with isochromosome 17q: A distinct entity with unique clinicopathologic and genetic featuresRashmi Kanagal-Shamanna, University of Texas MD Anderson Cancer Center, USA

Networking & Refreshment Break


Keynote ForumKeynote ForumIntroductionTitle: MicroRNAs in stored blood cells: What future do they hold in transfusion medicine?C D Atreya, U S Food and Drug Administration, USATitle: Molecular basis of acute myeloid leukemiaKen Mills, Queen’s University Belfast, UKTitle: 2016 WHO clinical molecular and pathological criteria for classification and staging of myeloproliferative neoplasms (MPN) caused by MPN driver mutations in the JAK2, MPL and CALR genes in the context of newJ J Michiels, Goodheart Institute, Netherlands

Title: Thrombotic complications in inherited bleeding disorders: The problem of aging populationPavol Holly, University Hospital Martin, SlovakiaTitle: Updates in markers of childhood leukemiaJackleen Awadallah Raafat, National Research Center, EgyptTitle: Target joint: New concept of identificationMousa Mohammad Thalath Alhaosawi, Almadinah General Hospital, Saudi ArabiaTitle: Resolve of the minors in inherited bloodAyesha Junaid, Shifa International Hospitals Ltd., PakistanVP: Preventing early relapse in breast cancer: Perioperative NSAID may prevent awakening of dormant single cells and avascular micrometastasesMichael Retsky, Harvard TH Chan School of Public Health, USA

Panel DiscussionDay 2 August 19, 2016

GuggenheumKeynote Forum

IntroductionTitle: Coagulopathy in traumatic brain injury: Current concepts and controversiesJohn Batchelor, Central Manchester Foundation Trust, UKTitle: Shotha and the Unified Theory of Inflammatory DiseasesRajavashisth Tripathi, Banaras Hindu University, India

Sessions: Treatment of Blood Disorder | Hematology ResearchSession Chair: Rajavashisth Tripathi, Banaras Hindu University, IndiaSession Co-chair: Visweshwar Nathan, University of South Florida, USA

Session IntroductionTitle: MicroRNA-1246 is a potential regulator of factor 8 geneC D Atreya, U S Food and Drug Administration, USA

Networking & Refreshment BreakTitle: Validity of on demand treatment in hemophilia patients based on patient's perception of a joint bleed impact on resources in developing countriesVisweshwar Nathan, University of South Florida, USATitle: Secondary myelofibrosis in the natural history of JAK2, MPL and CALR mutated myeloproliferative neoplasmsJ J Michiels, Goodheart Institute, NetherlandsTitle: Coagulation factor IX regulates cell migration and adhesion in vitroChiaki Hidai, Nihon University, JapanTitle: Proteomic variability and inflammation: Novel biomarkers and pathwaysRajavashisth Tripathi, Banaras Hindu University, IndiaTitle: Glucose 6 phosphate dehydrogenase (G6PD) enzyme deficiency in jaundiced infants in Khyber PakhtunkhwaShahtaj Khan, Hayatabad Medical Complex, Pakistan

Lunch BreakTitle: Interpreting circulating immature plasma cells in plasma cell leukemia using 5 part differential cell counterNishit Kumar Gupta, Nishit Clinical Laboratory Pvt. Ltd., IndiaTitle: Comparative study of serum ferritin level between pre and post menopausal women attending Usmanu Danfodiyo University Teaching Hospital (UDUTU), Sokoto, NigeriaErhabor Osaro, Usmanu Danfodiyo University, NigeriaSessions: Various aspects of Hematology | Case reports and EpidemiologySession Chair: Simon Durrant, University of Queensland, Australia

Session IntroductionTitle: Acquired hemophilia properly diagnosed, successfully treated: A report of 9 casesBozena Sokolowska, Medical University of Lublin, PolandTitle: Survival and clinical aspects for patients with chronic lymphocytic leukemia in Kermanshah, IranMehrdad Payandeh, Kermanshah University of Medical Sciences, Iran

Networking & Refreshment BreakTitle: Advances in stem cell and gene therapy for hemophiliaNaser Mobarra, University of Medical Sciences, Iran

Title: Epidemiology of lymphoma associated HTLV1Zahra Mozaheb, Mashhad University of Medical Science, IranTitle: Assessment of some hematological parameters of mortuary workers exposed to embalming chemicals in some mortuaries in Anambra state, NigeriaWinifred Onwurah, Nnamdi Azikiwe University, NigeriaVP: Frequency and management of venous thrombosis in adult acute leukemia patients at a tertiary care hospital of PakistanM Shahzad Sarwar, Aga Khan University Hospital, Pakistan

Poster PresentationPanel DiscussionAward Ceremony

466th OMICS International Conference

Blood Malignancies & TreatmentApril 18-19, 2016 Dubai, UAE

4th International Conference on

conferenceseries.com

Scientific Program

OMICS International Conferences2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA

Phone: +1-888-843-8169, Fax: +1-650-618-1417, Toll free: +1-800-216-6499Email: [email protected], [email protected]

Keynote ForumIntroductionInnovative immunotherapy for prevention and treatment of relapse following conventional chemotherapy or stem cell transplantationShimon Slavin, International Center for Cell Therapy & Cancer Immunotherapy, Israel

Networking & Refreshment Break @ FoyerSession Introduction

Track 1 : Blood Malignancies Track 2 : LeukemiaSession Chair: John Batchelor, Central Manchester Foundation Trust, UKSession Co-Chair: Slobodanka Ostojic Kolonic, Clinical Hospital Merkur, Croatia

Title: The pathogenesis of spontaneous intracranial haemorrhage in patients with haematological malignancy John Batchelor, Central Manchester Foundation Trust, UKTitle: Stratifying patients for immune checkpoint blockade cancer therapiesJean Jacques Fournié, Cancer Research Center of Toulouse, FranceTitle: Rituximab maintenance in follicular lymphomaSlobodanka Ostojic Kolonic, Clinical Hospital Merkur, CroatiaTitle: Systemic AL amyloidosis - Novel approaches to treatmentAshutosh Wechalekar, University College London, UK

Group PhotoLunch Break @ Foyer

Title: Acute myeloid leukemia in the elderlyMichael Keng, University of Virginia, USATitle: Stem cells microenvironment and its effects on leukemia treatmentMalak Yahia Qattan, King Saud University, Saudi Arabia

Panel DiscussionSession Introduction

Track 3 : MyelomaTrack 4 : Myelodysplastic SyndromeTrack 5 : Childhood Hematological CancersSession Chair: Inga Mandac Rogulj, Clinical Hospital Merkur, Croatia

Title: Management of higher risk myelodysplastic syndromeInga Mandac Rogulj, Clinical Hospital Merkur, Croatia Title: Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patientsLamya Mohamed Ibrahim, Advanced Center For Daycare Surgery, UAETitle: Recent advances in the diagnosis of multiple myelomaChayya Rani Sherva, MLB Medical College, IndiaTitle: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi Arabia

Networking & Refreshment Break@ Foyer

Registrations Open

Day 1Monday, April 18, 2016

Scientific Program


Meeting Room 10

Title: Treatment and survival in patients with chronic myeloid leukemia in chronic phase (CML-CP) in West IranMehrdad Payandeh, Kermanshah University of Medical Sciences, IranTitle: Report of 20 years’ experience on the effect of intensive intrathecal hemotherapy on prognosis of childhood lymphoblastic leukemia with central nervous system (CNS) involvementMahdi Shahriari, Shiraz University of Medical Sciences, IranTitle:Biological and molecular effects of selective inhibitor of ‘Aurora Kinase B’ (Barasertib) on a human promyelocytic leukemia cell lineFarhad Zaker, Iran University of Medical Sciences, Iran

Panel Discussion

Day 2Meeting Room 10

Tuesday, April 19, 2016Session Introduction

Track 6 : Blood Cancer DiagnosisTrack 7 : Blood Cancer : Causes & SymptomsTrack 8 : Blood Cancer StagingSession Chair: Elena Zakharova, Botkin Memorial Teaching Hospital, RussiaTitle: Renal consequences of blood malignancies Elena Zakharova, Botkin Memorial Teaching Hospital, RussiaTitle: Retrospective analysis of allele specific oligonucleotide-polymerase chain reaction , as method for detection three BCR-ABL linase mutations (T315I, M351T AND F311L) in chronic myelogenous leukemia patients treated with Imatinib Mesylate (TKI).Mukul Arvind Gharote, Gujarat Cancer Research Institute, India

Networking & Refreshment Break @ FoyerTitle: How to overcome challenges met with during chemotherapy for childhood acute myeloid leukemiaTaha Khattab, King Salman Military Hospital, Saudi ArabiaTitle: Cytogenetic heterogeneity as a prognostic indicator in acute myeloid leukemia patients from India Pina J Trivedi, Gujarat Cancer Research Institute, IndiaTitle: Phase III of study of R-CHOP-21 vs. R-CHOP-14 for untreated stage III and IV B-cell non-hodgkin's lymphoma: A report from IranMehrdad Payandeh, Kermanshah University of Medical Sciences, Iran

Session IntroductionTrack 9 : Blood Cancer : Treatment & CareTrack 10 : Bone Marrow Transplantation & SurgeryTrack 11 : Blood Cancer : Other AspectsSession Chair: Al-Jawhara Al-Manea, King Fahad Military Hospital, Saudi ArabiaTitle: Hematopoietic stem cell transplantation (HSCT) in childhood leukemiaAl-Jawhara Al-Manea, King Fahad Military Hospital, Saudi ArabiaTitle: Survivin as prognostic and predictive factor in patients treated with gemcitabine, dexamethasone, and cisplatin for relapsed or refractory aggressive NHLLamiss Mohamed Abd Elaziz, Tanta university, Egypt

Lunch Break @ FoyerTitle: BAX gene as a novel expressed tumor associated antigen in acute lymphoblastic leukemiaAmr Mohamed Gawaly, Tanta University, EgyptTitle: The possible involvement of epstein–barr virus in the etiology of leukemia in sudanese patientsHaitham Eltigani Mohammed Ealawad, Omdurman Islamic University, SudanTitle: Serum cancer antigen 15.3 concentrations in patients with betathalassemia minor compared to those with cancer and healthy individualsMahdi Shahriari, Shiraz University of Medical Sciences, Iran

Young Researchers Forum

Website: http://bloodmalignancies.conferenceseries.com/

OMICS Group Inc.2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA

Ph: +1-888-843-8169Fax: +1-650-618-1417

[email protected]

OMICS International5716 Corsa Ave., Suite 110, Westlake

Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414

[email protected]

OMICS InternationalSEZ Unit, Building No. 20, 9th Floor

APIIC Layout, HITEC CityHyderabad-500081, Telangana, INDIA

Ph: 040-40131823, [email protected]

Toll freeUSA & Canada: +1-800-216-6499

Australia: +1-800-651-097Europe: 0805-080048

Bookmark your dates7th International Conference on

May 25-26, 2017 London, UKBlood Cancer & Treatment

Title: Interrelationships among regulatory cells in patients with lymphoproliferative disordersZahra Al-Qarni, Sultan Qaboos University, OmanTitle: Timely strategies by oncology pharmacist to combat drug shortagesNaureen Wajid, American Hospital Dubai, UAETitle: Assessment of responsiveness in non-hodgkin lymphoma patients treated with chemotherapy in King Abdulaziz Hospital-Al Ahsa, KSAAreeg Bala Elbahsire Moahmed Ahmed, King Abdulaziz Hospital-Al Ahsa, KSATitle: Clinical characteristics and outcome of acute lymphoblastic leukemia in children in King Abdulaziz Medical City RiyadhTalal Hussein Alshareef, King Saud bin Abdulaziz University for Health Sciences, KSA

Networking & Refreshment Break @ FoyerPoster Session 15:35-16:15

BC-01Title: Frondoside a potentiates the effects of conventional therapeutic agents in acute leukemiaFatma H Sajwani, United Arab Emirates University, UAE

BC-02Title: Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell linesAmani Mahbub, Umm Al Qura University, Saudi Arabia

BC-03Title: Mucocutaneous relapse as unusual presentation of T-lineage acute lymphoblastic leukemiaMahdi Shahriari, Shiraz University of Medical Sciences, Iran

BC-04Title: Umbilical cord derived mesenchymal stem cell enhanced the expression of myeloid lineage related antigens on differentiated hematopoietic stem cellMohadese Hashem Boroojerdi, University Putra Malaysia, Malaysia

BC-05Title: Hypothesis: Fingolimod could lift the burden of lymphomaArsalan Azimi, Shiraz University of Medical Sciences, Iran

Awards CeremonyPanel Discussion

Thanks giving & Closing ceremony

OMICS International Conferences:2360 Corporate Circle, Suite 400 Henderson, NV 89074:7722, USA

Ph: +1:888:843:8169, Fax: +1:650:618:1417, Toll free: +1:800:216:6499Email: [email protected]; [email protected]

Hematology & Blood DisordersNovember 02-04, 2015 Atlanta, USA

3rd International Conference on

Scientific Program

Media Partners

Collaborator

Registrations

Day 1 November 02, 2015

Group PhotoNetworking & Refreshments Break @ Foyer

Track 1: Hematologic MalignanciesSession Chair: Ken Mills, Queen’s University Belfast, UKSession Co-Chair: Ulla Randen, Oslo University Hospital, Norway

Session IntroductionTitle: The current landscape of myelodysplastic syndromes Michael Keng, University of Virginia, USATitle: Identifying novel epigenetically induced synthetic lethality therapeutic combinations for high risk MDS/AMLKen Mills, Queen’s University Belfast, UKTitle: Effect of intestinal microbiota on lymphoma and longevity in Atm deficient miceRobert H Schiestl, University of California, USATitle: Primary cold agglutinin disease (CAD) associated lymphoproliferative disease: A new entityUlla Randen, Oslo University Hospital, NorwayTitle: The therapeutic potential of the translation initiation factor eIF2α serine 51 phosphorylation for chronic myeloid leukemiaKatarzyna Piwocka, Nencki Institute of Experimental Biology, Poland

Lunch Break @ RestaurantTitle: Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reactionAbdel Rahim Mahmoud Muddathir, Taibah University, KSATilte: CD5-positive B-cell lymphomasC Cameron Yin, University of Texas, USA

Special Session on Acquired thrombotic thrombocytopenic purpura: Disease pathogenesis, laboratory monitoring and current treatment strategies by

Jay S Raval, University of North Carolina, USATrack 2: Blood- Components and FunctionsTrack 3: Hemato-immunology & Stem Cell ResearchSession Chair: Dianzheng Zhang, Philadelphia College of Osteopathic Medicine, USASession Co-Chair: Jay S Raval, University of North Carolina, USATitle: MicroRNA as biomarker for acute graft versus host diseaseDianzheng Zhang, Philadelphia College of Osteopathic Medicine, USATitle: Role of antioxidants and polyphenols in thrombosis and haemostatic functionAbishek B Santhakumar, Central Queensland University, AustraliaTitle: Dendritic cell-based cancer immunotherapyShigetaka Shimodaira, Shinshu University Hospital, Japan

Networking & Refreshments Break @ Foyer

Opening CeremonyKeynote Forum

IntroductionRobert H SchiestlUniversity of California, USA

C Cameron YinUniversity of Texas, USA

Hematology & Blood DisordersNovember 02-04, 2015 Atlanta, USA

3rd International Conference on Scientific Program

Grand Salon C

Title: Effect of group of genetic markers on induction of fetal hemoglobin and disease severity in hemoglobinopathiesAnita Nadkarni, National Institute of Immunohematology, IndiaTitle: Cytogenetic biomarkers as indicators of the absorbed dose in the peripheral leukocytes of head & neck cancer patients undergoing radiotherapyShyama Soorambail Keshava, Goa University, IndiaTitle: Single donor versus pooled random donor platelet concentrates: A review of literatureSayeedul Hasan Arif, Jawaharlal Nehru Medical College, India

Panel Discussion

Day 2 November 03, 2015Grand Salon C

Knox Van DykeWest Virginia University, USARobert Michael DavidsonThe American Institute of Stress, USA

Keynote Forum

Networking & Refreshments Break @ FoyerTrack 4: Diagnosis, Treatment and Management of Blood DisordersSession Chair: Rania A Zayed, Cairo University, Egypt

Session IntroductionTitle: Risk factors for intracranial haemorrhage in elderly patients with blunt head traumaJohn S Batchelor, Central Manchester Foundation Trust, UKTitle: Characterization of RBC mechanical properties by microfluidic techniquesAnnie Viallat, University Aix-Marseille, FranceTitle: Indoleamine 2,3 dioxygenase and regulatory T cells in acute myeloid leukemiaRania A Zayed, Cairo University, EgyptTitle: Kozhikode Criteria’ for diagnosing SLE as a Haematological Disorder P K Sasidharan, University of Calicut, IndiaTitle: Blood transfusion reaction in pediatric age group: A tertiary care centre based studySuhailur Rehman, Aligarh Muslim University, India

Lunch Break @ RestaurantSpecial Session on New Drug Development in Hematology by

Knox Van Dyke, West Virgina University, USA & Erhabor Osaro, Usmanu Danfodiyo University, Nigeria

Networking & Refreshments Break @ FoyerYoung Researchers Forum

Title: Adult T-cell leukemia/lymphoma (ATLL): Where we are in 2015Nikhil Mukhi, SUNY Downstate Medical Center, USATitle: Post-ERCP pancreatitis: A rare cause of atypical hemolytic uremic syndromeSuresh Manapuram, Allegheny General Hospital, USATitle: The role of different aggregating agents in the inhibition of nitric oxide synthesis in platelet aggregationDebipriya Banerjee, Sinha Institute of Medical Science & Technology, IndiaTitle: Correlative study of Mentzer’s index, RDWI and Hb electrophoresis for β-thalassemia traitSuhailur Rehman, Aligarh Muslim University, IndiaTitle: Hemophilia- Evolution and challenges in MadagascarOlivia Ndjib, Antananarivo University, Madagascar

Poster PresentationPanel Discussion

Day 3 November 04, 2015Grand Salon C

Symposium on Tropical Blood Disorders byErhabor Osaro, Usmanu Danfodio University, Nigeria

Session Chair: Erhabor Osaro, Usmanu Danfodiyo University, Nigeria Session Introduction

Title: Effect of Plasmodium parasitaemia on some haematological parameters in children living in sokoto, North Western, NigeriaErhabor Osaro, Usmanu Danfodiyo University, Nigeria

Title: Gene expression of P-selectin in malaria infectionOkorie Hope Mery, Imo State University, NigeriaTitle: Effect of malaria infection on packed cell volume and haemoglobin levels among patients at OJO district of lagos state NigeriaIwunze Vincent Okechukwu, Life-link Medical Diagnostic & Labs. Ltd , Nigeria

Networking & Refreshments Break 1@ FoyerTitle: Disharmony and lack of teamwork among health professionals; an emerging challenge in the management of blood disorders in NigeriaEmmanuel Kufre Uko, University of Calabar, NigeriaTitle: Screening for HBsAg and HCV antibodies among military personnel in the Niger Delta of NigeriaAzuonwu Obioma, University of Science and Technology Port, Nigeria Title: Changes in some haemostatic parameters in pregnancy and peurperium in Port HarcourtEchonwere Beauty, Rivers State University of Science and Technology , NigeriaTitle: Malaria parasitaemia among long distance truck drivers in the Niger delta of NigeriaFredrick Christy C, University of Abuja, Nigeria

Special Session on Biophysical aspects of the Sanarelli-Shwartzman phenomenon byRobert Michael Davidson, The American Institute of Stress, USA

Lunch Break@ RestaurantTrack 5: Various Aspects of HematologySession Chair: Harald Engan, Mid Sweden University, Sweden

Session IntroductionTitle: Hemoconcentration following spleen contractionHarald Engan, Mid Sweden University, SwedenTitle: Epidemiological aspects of intrafamilial spread of HCV iInfection in Egyptianp Population: A pilot studyDalia Omran, Cairo University, EgyptTilte: Extramedullary plasmablastic plasma cell myeloma presenting as plasmablastic lymphomaAmar Ranjan, All India Institute of Medical Sciences, IndiaTitle: The effect of hematology in African hospitals and patientsUdodirim Evelyn Okoro, Federal Medical Center Umuahia, NigeriaTitle: Serum prohepcidin and iron metabolism in chloramphenicol induced anaemia in ratsChristopher Chijindu Osubor, University of Benin, NigeriaTitle: Challenges associated with the effective management of major haemorrhage in developing countriesErhabor Osaro, Usmanu Danfodiyo University, Nigeria

Networking & Refreshments Break @ FoyerClosing Ceremony

Bookmark your dates

OMICS Group Inc.2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA

Ph: +1-888-843-8169Fax: +1-650-618-1417

[email protected]

OMICS International5716 Corsa Ave., Suite 110, Westlake

Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414

[email protected]

OMICS GroupSEZ Unit, Building No. 20, 9th Floor

APIIC Layout, HITEC CityHyderabad-500081, Telangana, INDIA

Ph: 040-40131823, [email protected]

Toll freeUSA & Canada: +1-800-216-6499

Australia: +1-800-651-097Europe: 0805-080048

April 18-20,2016 Dubai, UAE

4th International Conference on

Blood Malignancies & TreatmentWebsite: bloodmalignancies.conferenceseries.com

e-mail: [email protected]; [email protected]

August 18-20, 2016 London, UK

5th World Congress on

Haemophilia and Blood DisordersWebsite: hemophilia.conferenceseries.com

e-mail: [email protected]; [email protected]

ematologists tentative rogram · title: paroxysmal nocturnal hemoglobinuria: a multicenter study...

Documents